HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 16Generated: October 23, 2026
5-fluoro-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amine → 5-Fluoro-N-(2-fluoro-4-(morpholinomethyl)phenyl)-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amine
https://huagongshe.com/en/reaction/16
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 5-fluoro-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amine | HCID 16665498 | — |
| Reactant | 4-(4-Bromo-3-fluorobenzyl)morpholine | HCID 53417818 | — |
| Reagent | Sodium 2-methylbutan-2-olate | HCID 2733478 | — |
| Catalyst | Palladium | HCID 23938 | — |
| Catalyst | Tri-o-tolylphosphine | HCID 80271 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | 5-Fluoro-N-(2-fluoro-4-(morpholinomethyl)phenyl)-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amine | HCID 49782013 | 88% |
Reaction Steps
The aim of the reaction is test/optimization: 5-fluoro-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amine (100 mg, 0.36 mmol), 4-(4-bromo-3-fluorobenzyl)morpholine (109 mg, 0.40 mmol), Palladium, 10% On Charcoal (115 mg, 0.11 mmol), Tri-o-tolylphosphine (49.4 mg, 0.16 mmol) and Sodium tert-pentoxide (79 mg, 0.72 mmol) were dissolved in toluene (1.5 mL) and heated to 110 °C under argon. The reaction was monitorred by HPLC. After 16 h 88 % conversion was achieved. The reaction was stopped and the mixture was discarded.
Provenance & Evidence
| Source dataset | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-b9ea1ddb99074c47af3b567d6c34306c |
|---|
| Source note | 750 AstraZeneca ELN dataset |
|---|